Photo by isensusa from unsplash
Highlights • Non gestational choriocarcinoma is diagnosed by history, pathology, & genetics.• There is a paucity of data regarding the efficacy of immunotherapy in this disease.• Hyperprogression on immunotherapy can… Click to show full abstract
Highlights • Non gestational choriocarcinoma is diagnosed by history, pathology, & genetics.• There is a paucity of data regarding the efficacy of immunotherapy in this disease.• Hyperprogression on immunotherapy can occur in gynecologic malignancies.• Hyperprogression was associated with aberrations in the CHEK2/TP53 pathway.
Keywords:
hyperprogression pembrolizumab;
choriocarcinoma hyperprogression;
gestational choriocarcinoma;
hyperprogression;
non gestational
Journal Title: Gynecologic Oncology Reports
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Gynecologic Oncology Reports
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!